ARCHIVES

In Brief: BMS Oncology Names New VP, Marketing; Hortobagyi Wins Freyer Medal; Prerez Honored

This article is from The Cancer Letter archive.

Vol. 23 No. 41 | October 24, 1997

Download PDF Visit The Full Archive

Related Articles

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

June 25, 2010

“Proof Of Concept” Shown In Early Trial Of PKC-412

December 27, 2002

Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer

November 28, 2014

House-Senate Conferees Approve $6 Million Centers Amendment to Supplemental Appropriations Bill

June 27, 1986

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

April 26, 1996

NCI, Litton Open Talks On Frederick Contract

February 6, 1976